- Home
- NIPG vs CLYM Comparison
NIPG vs CLYM Comparison
Compare NIPG & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIPG
- CLYM
- Stock Information
- Founded
- NIPG 2014
- CLYM 2018
- Country
- NIPG Sweden
- CLYM United States
- Employees
- NIPG N/A
- CLYM N/A
- Industry
- NIPG
- CLYM
- Sector
- NIPG
- CLYM
- Exchange
- NIPG NYSE
- CLYM NYSE
- Market Cap
- NIPG 96.4M
- CLYM 83.8M
- IPO Year
- NIPG 2024
- CLYM 2021
- Fundamental
- Price
- NIPG $2.41
- CLYM $1.37
- Analyst Decision
- NIPG Strong Buy
- CLYM Buy
- Analyst Count
- NIPG 1
- CLYM 1
- Target Price
- NIPG $6.00
- CLYM $10.00
- AVG Volume (30 Days)
- NIPG 406.8K
- CLYM 397.5K
- Earning Date
- NIPG 04-30-2025
- CLYM 08-13-2025
- Dividend Yield
- NIPG N/A
- CLYM N/A
- EPS Growth
- NIPG N/A
- CLYM N/A
- EPS
- NIPG N/A
- CLYM N/A
- Revenue
- NIPG $85,266,306.00
- CLYM N/A
- Revenue This Year
- NIPG $11.25
- CLYM N/A
- Revenue Next Year
- NIPG $33.33
- CLYM N/A
- P/E Ratio
- NIPG N/A
- CLYM N/A
- Revenue Growth
- NIPG 1.91
- CLYM N/A
- 52 Week Low
- NIPG $0.99
- CLYM $1.05
- 52 Week High
- NIPG $17.76
- CLYM $9.21
- Technical
- Relative Strength Index (RSI)
- NIPG N/A
- CLYM N/A
- Support Level
- NIPG N/A
- CLYM N/A
- Resistance Level
- NIPG N/A
- CLYM N/A
- Average True Range (ATR)
- NIPG 0.00
- CLYM 0.00
- MACD
- NIPG 0.00
- CLYM 0.00
- Stochastic Oscillator
- NIPG 0.00
- CLYM 0.00
About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS
NIP Group Inc is a digital entertainment company built for the growing gaming and esports industry. NIP Group integrates multiple businesses such as talent agency, event production, game-themed hotels and game publishing to create transformative entertainment experiences that inspire, connect fans, expand influence globally, and achieve deep interaction on platforms where digital native players gather. It currently has operation centers in Sweden, China, Abu Dhabi, and Brazil, and its esports teams cover multiple game projects and are active in the top event stages.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.